DNA methylation in haematological malignancies: the role of decitabine

Author： Hennessy Bryan T Garcia-Manero Guillermo Kantarjian Hagop M Giles Francis J

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.12, 2003-12, pp. : 1985-1993

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in the treatment for haematological malignancies

By Piccaluga Pier Paolo Martinelli Giovanni Baccarani Michele

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 721-732

Informa Healthcare

Access to resources Recommend Favorite

The Role of DNA Methylation in the Pathogenesis and Treatment of Cancer

Current Clinical Pharmacology, Vol. 7, Iss. 4, 2012-11 ,pp. : 333-340

Bentham Science Publishers

Access to resources Recommend Favorite

Arsenic trioxide in the treatment of haematological malignancies

By Kwong Yok-Lam

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 589-597

Informa Healthcare

Access to resources Recommend Favorite

IAPs as therapeutic targets in haematological malignancies

By Langemeijer SMC de Graaf AO Jansen JH

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 981-993

Informa Healthcare

Access to resources Recommend Favorite

Nucleoside analogues in the treatment of haematological malignancies

By Johnson Stephen A

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 929-943

Informa Healthcare

Access to resources Recommend Favorite